Trending Health

In recent years, we’ve seen an increasing number of Life Sciences companies publicly declare commitments to sustainability efforts as a result of increased pressure from governments, customers, and research. Trending Health UK’s Ollie May sits down with two members of Vynamic’s Sustainability Council, Rosanna Vellacott and Matt O’Dell, to discuss why pharmaceutical organizations should be paying a...

In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the introduction of rebate credits by CVS to account for more biosimilars entering the market, as well as a recent ruling by a federal appeals court that drugmakers cannot restrict 340B program offerings from community and specialty pharmacies. Finally, we discuss a groundbreaking procedure in which a...

One of the core tenets of the omnichannel philosophy is continuous learning and refinement – bringing together experience and data to evolve the marketing and model. Jen is joined by Vynamic’s Customer Experience Transformation Lead Mike Zapiec and Omnichannel Offering Lead Josh Padams to discuss what we’ve learned partnering with clients to build their omnichannel capabilities and what Life Scien...

In this episode, Jack, Ollie, and Jen discuss a substantial investment package in the UK\’s Life Sciences and manufacturing sectors, the role of an AI chatbot in bridging Europe\’s mental health care gap, and how Spain is reshaping pharmaceutical supply chains in Europe.    Podcast Tags: healthcare, Europe, healthcare news, manufacturing, research, AI, chatbots, mental health, patient care, Spain,...

The obesity drug market has grown dramatically in the last few years, especially with the help of social media and influencers. The immense popularity of anti-obesity medications has transformed a health industry development into a cultural phenomenon. While this market has so much opportunity, it also faces supply issues and coverage gaps. Mindy and Jen are joined by Vynamic’s Head of Life Scienc...

Since it was signed into law in 2022, the health industry has been abuzz about the longer-term impact of the Inflation Reduction Act. In this episode, Jen & Mindy sit down to discuss recent headlines and developments around this landmark legislation and what Life Sciences companies should expect over the course of the next year. For more perspective on the Inflation Reduction Act\’s impact on...

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the ruling by Alabama’s Supreme Court that frozen embryos can be legally regarded as “extrauterine children” under state law, and the impact this decision has had on in vitro fertilization (IVF) procedures. They also cover the release of additional guidance from CMS on the Medicare Prescription Payment Plan and a new...

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, covering a prominent oncology society\’s push for tumor classification reform that could have profound impacts on cancer survival rates, the critical need for measles vaccination, and Sweden\’s pioneering use of drones in cardiac arrest intervention.  Podcast Tags: healthcare, healthcare news, life sciences,...

Over the last few years, the MedTech market has been navigating an unpredictable environment due to macro-economic factors and pandemic-driven activity. As we start off 2024, there’s a prevailing feeling that this market is finally starting to stabilize. In this episode, Jen is joined by Vynamic’s Anila Patel and Head of Health Technology Sector, Mary Virzi, to chat about what MedTech moves we’ve...

In this episode, Jen sits down with Vynamic’s Deal Activation & Partnership Enablement Service Leads, Senior Director Kevin Fletcher and Executive Sean Martin, to discuss recent newsworthy items coming out of the J.P. Morgan Healthcare Conference, including the major acquisitions and deals announced, particularly those focused on AI and digital innovation. Check out Vynamic’s Deal Activation &...

Within Life Sciences companies, Medical Affairs teams are tasked with gathering and communicating scientific data, a job that has only grown in importance as therapies have grown more complex and stakeholders have multiplied. Stretched in many directions and under high scrutiny, Medical Affairs teams need to be able to effectively measure and communicate the value of their work. In this deep dive...

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, including the potential impact of Wegovy in reducing excess deaths in the UK, a groundbreaking report on minimising the environmental footprint of surgical care, and Lithuania\’s  innovation wave in biotech and MedTech. Podcast Tags: healthcare, healthcare news, life sciences, obesity, medtech, sustainabilit...

The US Pharmacy Industry is the largest in the world, with many different players involved in ensuring pharmaceutical products reach consumers. These channels and distribution outlets have drastically changed over the years and will only continue to evolve. The pharmacy channel has reimagined how they are reaching patients, managing risks, and deriving value, expanding their business models beyond...

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the announcement that Bristol Myers Squibb is purchasing RayzeBio, the use of artificial intelligence in discovering antibiotics that stop MRSA infections, and recent reports revealing an increase in medical errors at hospitals owned by private equity firms. Podcast Tags: healthcare, healthcare news, life sciences, me...

In this special episode, we conclude our annual series on the biggest health industry trends of the next year. Jen sits down with Vynamic Senior Executives Karen Baldry, Mindy McGrath, and Ryan Hummel, and Executives Mary Virzi and Saurabh Raman to discuss the five trends they expect to be most impactful in 2024. These trends include 1) policy implications & judicial decisions, 2) realizing th...

In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Executive & Head of Health Technology Mary Virzi to discuss the five MedTech trends Mary expects to be most impactful in 2024. These trends include 1) increased research & development spend, 2) embracing remote patient monitoring, 3) spinoffs to expand access, 4)...

In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Senior Executive & Head of Life Sciences Karen Baldry to discuss the five Life Sciences trends Karen expects to be most impactful in 2024. These trends include 1) balancing innovation & affordability, 2) launching for value, 3) breaking down silos, 4) mastering om...

In this episode, Jen is joined by members of Vynamic’s London office to unpack key insights from two recent conferences. First, Senior Executive Gemma Pfister and Director Nick Fletcher discuss the recent Evidence Life Science Medical Affairs Insights & Omnichannel Conference in London. Then, Senior Directors Jack Young and Owen Thomas cover the Next Pharma Customer Experience Summit in Vienna...

In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Executive & Head of Payers Saurabh Raman to discuss the five Payer trends Saurabh expects to be most impactful in 2024. These trends include 1) product diversification and a strategic shift to government markets, 2) regulatory changes to Medicare, 3) improving care fo...

In this special minisode, we begin our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Senior Executive & Head of Providers Ryan Hummel to discuss the five Provider trends Ryan expects to be most impactful in 2024. These trends include 1) increased financial stability, 2) digitizing the patient experience, 3) accelerating health equity progress with partne...

Deals, mergers, partnerships, and acquisitions are key mechanisms as health organizations look to enter new markets, differentiate their value proposition, and achieve growth strategies. Despite a less than favorable economic environment, the health industry has seen some major headlines in this space this year. Jen and Mindy are joined by Vynamic’s Deal Activation & Partnership Enablement Ser...

Payer organizations are betting big on government markets, with some abandoning commercial opportunities entirely. In this episode, Jen is joined by two leaders in Vynamic\’s Health Services sector, Executive Saurabh Raman and Senior Director Keith Sutter to explore what this trend means for the health industry, the complexities involved in these markets, and the steps payers can take to guarantee...

In this episode, Mindy and Jen catch up on the impact that the Inflation Reduction Act has had on the health industry over the last year and look ahead to how life sciences organizations, payors, and providers can prepare for the changes that this legislation will cause.   If you missed our initial coverage of the Inflation Reduction Act, check out our Trending News episode from August 18, 2022 . ...

The growth of the biotech industry has become a recurring topic on Trending Health episodes, from headlines about Novo Nordisk products Ozempic and Wegovy, to the emergence of Moderna as a household name thanks to their mRNA COVID-19 vaccine. As more biotech companies emerge into the market, they bring with them a mix of challenges and opportunities. On this episode of Trending Health, Jen and Min...

The global medical device market is expected to grow at a compound rate of nearly 5% in the next few years – fueled by a forecasted uptick in product launches. On this episode, Jen is joined by Vynamic\’s Head of Health Technology Sector Mary Virzi and Senior Manager Christina Nikolos, to discuss how MedTech companies should approach launch to capitalize on this opportunity. For information about...